Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Meriem Belhocine"'
Autor:
Aurélie Chapdelaine, Alissar Mourad, Anne-Marie Mansour, Meriem Belhocine, Yves Troyanov, Maxime Doré
Publikováno v:
Can J Hosp Pharm
Background: Thiopurines are a mainstay of therapy for autoimmune diseases. However, up to 20% to 30% of patients experience overproduction of the methylated metabolites, known as 6-MMP, to the detriment of the active metabolite, 6-thioguanine nucleot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3613fba5c674463646e64969176fb79
https://pubmed.ncbi.nlm.nih.gov/34602624
https://pubmed.ncbi.nlm.nih.gov/34602624
Autor:
Valérie Bénard, Jean-Paul Makhzoum, Isabelle Chagnon, Tara Starnino, Rosalie-Sélène Meunier, Anne-Marie Mansour, Maxime Rhéaume, Farah Zarka, Guillaume Febrer, Nathalie Routhier, Michelle Goulet, Yves Troyanov, Stéphanie Ducharme-Bénard, Carolyn Ross, Meriem Belhocine
Publikováno v:
Rheumatology Advances in Practice
Objectives The aim was to compare the accuracy of colour Doppler ultrasonography (CDUS) and temporal artery biopsy (TAB) to establish the final diagnosis of GCA and to determine how the GCA probability score (GCAPS) performs as a risk stratification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aae9a84e2b48aeb963788c1e29d2e99
https://doi.org/10.1093/rap/rkab083
https://doi.org/10.1093/rap/rkab083
Autor:
V. Le Guern, Nicolas Martin Silva, Emmanuelle Pannier, Vassilis Tsatsaris, J.C. Piette, Nathalie Morel, Michel Dreyfus, N. Costedoat-Chalumeau, Maddalena Larosa, Meriem Belhocine, G. Guettrot Imbert, R. Paul, A. Ruffatti, Catherine Deneux-Tharaux, Andrea Doria, O. Souchaud-Debouverie, L. Mouthon
Publikováno v:
Annals of the Rheumatic Diseases. 79:364.2-364
Background:One of the 3 features of obstetrical antiphospholipid syndrome (APS) is severe preeclampsia (PE). Its time of occurrence, the associated risk of thromboses and systemic lupus erythematosus (SLE) have not been reported yet.Objectives:We ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::150b036aee3a1c7e17aa7db2b6e8fb5d
https://doi.org/10.1136/annrheumdis-2020-eular.5901
https://doi.org/10.1136/annrheumdis-2020-eular.5901
Autor:
L. Mouthon, C. Le Jeunne, Meriem Belhocine, M. Fredi, Laetitia Coutte, J.C. Piette, V. Le Guern, N. Costedoat-Chalumeau, Anthony Chauvin, Romain Paule, Nathalie Morel
Publikováno v:
SLE, Sjögren’s and APS – clinical aspects (other than treatment).
Background The diagnosis of systemic lupus erythematosus (SLE) is based on the association of clinical and biological manifestations and on clinical experience. In 2012, a major revision by the Systemic Lupus International Collaborating Clinics (SLIC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3b7c6a8ecc67204beda178b458a169
https://doi.org/10.1136/annrheumdis-2018-eular.3207
https://doi.org/10.1136/annrheumdis-2018-eular.3207
Autor:
Anthony Chauvin, Claire Le Jeunne, Meriem Belhocine, Jean-Charles Piette, Nathalie Morel, N. Costedoat-Chalumeau, Micaela Fredi, Luc Mouthon, Laetitia Coutte, Romain Paule, Véronique Le Guern
Publikováno v:
Autoimmunity reviews. 17(9)
Objectives To assess the limitations of the SLICC (Systemic Lupus International Collaborating Clinics) classification criteria for systemic lupus erythematosus (SLE), in patients with primary antiphospholipid syndrome (PAPS). Methods Retrospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed565da11fabc28ec79e54b194c850d4
https://pubmed.ncbi.nlm.nih.gov/30005859
https://pubmed.ncbi.nlm.nih.gov/30005859
Autor:
Chiara Stagnaro, Cristina Lavilla Olleros, Meriem Belhocine, Marta Mosca, Elena Elefante, Chiara Tani, Guillermo Ruiz-Irastorza, R. Vagelli, Nathalie Costedoat-Chalumeau, Miguel Martin-Cascon
Publikováno v:
Lupus Science & Medicine
ObjectivesTo analyse the real-life practice on the use of Tacrolimus (TAC) in patients with systemic lupus erythematosus (SLE) from three European SLE referral centres.MethodsAdult patients with SLE regularly followed at three European referral centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77fb79abf9e048154042453d3ec2cb23
http://hdl.handle.net/11568/946290
http://hdl.handle.net/11568/946290
Autor:
N. Costedoat-Chalumeau, Anthony Chauvin, Meriem Belhocine, L. Mouthon, Romain Paule, C. Le Jeunne, M. Fredi, Laetitia Coutte, J.C. Piette, V. Le Guern, Nathalie Morel
Publikováno v:
La Revue de Médecine Interne. 38:A79-A80
Introduction Le syndrome des antiphospholipides (SAPL) peut exister isolement (SAPL primaire) ou etre associe a une autre pathologie, generalement un lupus systemique (LS). De nouveaux criteres de classification du LS ont ete etablis par le groupe Sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7df42e22cf047c0a76485db01200634
https://doi.org/10.1016/j.revmed.2017.10.370
https://doi.org/10.1016/j.revmed.2017.10.370
Autor:
Romain Paule, Michel Dreyfus, G. Guettrot Imbert, Laetitia Coutte, J.C. Piette, V. Le Guern, O. Souchaud-Debouverie, Nathalie Morel, M. Fredi, N. Costedoat-Chalumeau, Meriem Belhocine, N. Martin-Silva
Publikováno v:
La Revue de Médecine Interne. 38:A76
Introduction Le syndrome des antiphospholipides (SAPL) est defini par une combinaison de thromboses arterielles et/ou veineuses, de complications obstetricales (3 fausses couches spontanees successives, mort fœtale a partir de 10 semaines d’amenor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6b62baede12403dcca9b41c687e384
https://doi.org/10.1016/j.revmed.2017.10.365
https://doi.org/10.1016/j.revmed.2017.10.365
Autor:
Maddalena Larosa, Véronique Le Guern, Nathalie Morel, Mériem Belhocine, Amelia Ruffatti, Nicolas Martin Silva, Romain Paule, Luc Mouthon, Michel Dreyfus, Jean-Charles Piette, Odile Souchaud-Debouverie, Catherine Deneux-Tharaux, Gaelle Guettrot-Imbert, Vassilis Tsatsaris, Emmanuelle Pannier-Metzger, Anne Murarasu, Andrea Doria, Nathalie Costedoat-Chalumeau
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-5 (2021)
Abstract Background The criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied. Thus, we rep
Externí odkaz:
https://doaj.org/article/fbe6fa4206e240a2a56cd519b79997ae
Autor:
Mériem Belhocine, Laetitia Coutte, Nicolas Martin Silva, Nathalie Morel, Gaëlle Guettrot-Imbert, Romain Paule, Claire Le Jeunne, Micaela Fredi, Michel Dreyfus, Jean-Charles Piette, Odile Souchaud-Debouverie, Catherine Deneux-Tharaux, Vassilis Tsatsaris, Emmanuelle Pannier, Véronique Le Guern, Nathalie Costedoat-Chalumeau
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-8 (2018)
Abstract Objective Although one of the three obstetric manifestations of antiphospholipid syndrome (APS) is intrauterine fetal death (IUFD), little is known about it in this context. We report the first large series of patients with APS and IUFD. Met
Externí odkaz:
https://doaj.org/article/519d659537de44caaabe7b3b657a1844